PHL-CARBAMAZEPINE CR DIN 02238641
Health Canada record
| Active ingredient(s) | CARBAMAZEPINE 400 MG |
|---|---|
| Dosage form | Tablet (Extended-Release) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N03AF01 CARBAMAZEPINE |
| Original market date | 03-Sep-1998 |
| Current status date | 26-Oct-2009 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pharmel Inc. — licence 101409, not currently licensed, last inspection rating C (2018-01-15).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CARBAMAZEPINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02242908 | APO-CARBAMAZEPINE CR | APOTEX INC | Tablet (Extended-Release) | CARBAMAZEPINE 200 MG | Approved |
| 02242909 | APO-CARBAMAZEPINE CR | APOTEX INC | Tablet (Extended-Release) | CARBAMAZEPINE 400 MG | Approved |
| 02571269 | AURO-CARBAMAZEPINE | AURO PHARMA INC | Tablet | CARBAMAZEPINE 200 MG | Approved |
| 02541238 | MINT-CARBAMAZEPINE | MINT PHARMACEUTICALS INC | Tablet | CARBAMAZEPINE 200 MG | Marketed |
| 02261839 | SANDOZ-CARBAMAZEPINE CR | SANDOZ CANADA INCORPORATED | Tablet (Extended-Release) | CARBAMAZEPINE 200 MG | Marketed |
| 02261847 | SANDOZ-CARBAMAZEPINE CR | SANDOZ CANADA INCORPORATED | Tablet (Extended-Release) | CARBAMAZEPINE 400 MG | Marketed |
| 02367394 | TARO-CARBAMAZEPINE | TARO PHARMACEUTICALS INC | Suspension | CARBAMAZEPINE 100 MG | Marketed |
| 02244403 | TARO-CARBAMAZEPINE CHEWABLE TABLETS | TARO PHARMACEUTICALS INC | Tablet (Chewable) | CARBAMAZEPINE 100 MG | Marketed |
| 02244404 | TARO-CARBAMAZEPINE CHEWABLE TABLETS | TARO PHARMACEUTICALS INC | Tablet (Chewable) | CARBAMAZEPINE 200 MG | Marketed |
| 00010405 | TEGRETOL | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | CARBAMAZEPINE 200 MG | Marketed |
| 00755583 | TEGRETOL CR | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet (Extended-Release) | CARBAMAZEPINE 400 MG | Marketed |
| 00773611 | TEGRETOL CR | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet (Extended-Release) | CARBAMAZEPINE 200 MG | Marketed |
| 02194333 | TEGRETOL SUSPENSION | NOVARTIS PHARMACEUTICALS CANADA INC | Suspension | CARBAMAZEPINE 100 MG | Marketed |
| 00782718 | TEVA-CARBAMAZEPINE | TEVA CANADA LIMITED | Tablet | CARBAMAZEPINE 200 MG | Marketed |
| 00402699 | APO-CARBAMAZEPINE | APOTEX INC | Tablet | CARBAMAZEPINE 200 MG | Dormant |
| 02247135 | BIO-CARBAMAZEPINE | BIOMED PHARMA | Tablet | CARBAMAZEPINE 200 MG | Cancelled Post Market |
| 00578460 | CARBAMAZEPINE 200 TAB 200MG | PRO DOC LIMITEE | Tablet | CARBAMAZEPINE 200 MG | Cancelled Post Market |
| 02232755 | CARBAMAZEPINE 200MG TABLETS | LABORATOIRES CONFAB INC | Tablet | CARBAMAZEPINE 200 MG | Cancelled Pre Market |
| 02413604 | CARBAMAZEPINE CR | PRO DOC LIMITEE | Tablet (Extended-Release) | CARBAMAZEPINE 400 MG | Cancelled Post Market |
| 02413590 | CARBAMAZEPINE CR | PRO DOC LIMITEE | Tablet (Extended-Release) | CARBAMAZEPINE 200 MG | Cancelled Post Market |
| 02243511 | CARBAMAZEPINE-CR -(200MG) | PRO DOC LIMITEE | Tablet (Extended-Release) | CARBAMAZEPINE 200 MG | Cancelled Post Market |
| 02243512 | CARBAMAZEPINE-CR -(400MG) | PRO DOC LIMITEE | Tablet (Extended-Release) | CARBAMAZEPINE 400 MG | Cancelled Post Market |
| 02231670 | DOM-CARBAMAZEPINE | DOMINION PHARMACAL | Tablet | CARBAMAZEPINE 200 MG | Cancelled Pre Market |
| 02238223 | DOM-CARBAMAZEPINE CR | DOMINION PHARMACAL | Tablet (Extended-Release) | CARBAMAZEPINE 400 MG | Cancelled Post Market |
| 02238222 | DOM-CARBAMAZEPINE CR | DOMINION PHARMACAL | Tablet (Extended-Release) | CARBAMAZEPINE 200 MG | Cancelled Post Market |
| 00504742 | MAZEPINE | BIOMED PHARMA | Tablet | CARBAMAZEPINE 200 MG | Dormant |
| 02241883 | MYLAN-CARBAMAZEPINE CR | MYLAN PHARMACEUTICALS ULC | Tablet (Extended-Release) | CARBAMAZEPINE 400 MG | Cancelled Post Market |
| 02241882 | MYLAN-CARBAMAZEPINE CR | MYLAN PHARMACEUTICALS ULC | Tablet (Extended-Release) | CARBAMAZEPINE 200 MG | Cancelled Post Market |
| 02042568 | NU-CARBAMAZEPINE TAB 200MG | NU-PHARM INC | Tablet | CARBAMAZEPINE 200 MG | Cancelled Post Market |
| 02238640 | PHL-CARBAMAZEPINE CR | PHARMEL INC | Tablet (Extended-Release) | CARBAMAZEPINE 200 MG | Cancelled Post Market |
| 02231540 | PMS-CARBAMAZEPINE | PHARMASCIENCE INC | Tablet (Chewable) | CARBAMAZEPINE 200 MG | Cancelled Post Market |
| 02231542 | PMS-CARBAMAZEPINE | PHARMASCIENCE INC | Tablet (Chewable) | CARBAMAZEPINE 100 MG | Cancelled Post Market |
| 02231541 | PMS-CARBAMAZEPINE | PHARMASCIENCE INC | Tablet | CARBAMAZEPINE 200 MG | Cancelled Pre Market |
| 00667110 | PMS-CARBAMAZEPINE | PHARMASCIENCE INC | Tablet | CARBAMAZEPINE 200 MG | Cancelled Post Market |
| 02280744 | PMS-CARBAMAZEPINE CR | PHARMASCIENCE INC | Tablet (Extended-Release) | CARBAMAZEPINE 200 MG | Cancelled Pre Market |
| 02280752 | PMS-CARBAMAZEPINE CR | PHARMASCIENCE INC | Tablet (Extended-Release) | CARBAMAZEPINE 400 MG | Cancelled Pre Market |
| 02231543 | PMS-CARBAMAZEPINE-CR | PHARMASCIENCE INC | Tablet (Extended-Release) | CARBAMAZEPINE 200 MG | Cancelled Post Market |
| 02231544 | PMS-CARBAMAZEPINE-CR | PHARMASCIENCE INC | Tablet (Extended-Release) | CARBAMAZEPINE 400 MG | Cancelled Post Market |
| 02261863 | SANDOZ-CARBAMAZEPINE CHEWTABS | SANDOZ CANADA INCORPORATED | Tablet (Chewable) | CARBAMAZEPINE 200 MG | Cancelled Post Market |
| 02261855 | SANDOZ-CARBAMAZEPINE CHEWTABS | SANDOZ CANADA INCORPORATED | Tablet (Chewable) | CARBAMAZEPINE 100 MG | Cancelled Post Market |
| 02407515 | TARO-CARBAMAZEPINE | TARO PHARMACEUTICALS INC | Tablet | CARBAMAZEPINE 200 MG | Cancelled Post Market |
| 02237908 | TARO-CARBAMAZEPINE CR | TARO PHARMACEUTICALS INC | Tablet (Extended-Release) | CARBAMAZEPINE 400 MG | Cancelled Post Market |
| 02237907 | TARO-CARBAMAZEPINE CR | TARO PHARMACEUTICALS INC | Tablet (Extended-Release) | CARBAMAZEPINE 200 MG | Cancelled Post Market |
| 02052423 | TARO-CARBAMAZEPINE TAB 200MG | TARO PHARMACEUTICALS INC | Tablet | CARBAMAZEPINE 200 MG | Cancelled Post Market |
| 00369810 | TEGRETOL CHEWTABS 100 MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet (Chewable) | CARBAMAZEPINE 100 MG | Cancelled Post Market |
| 00665088 | TEGRETOL CHEWTABS 200 MG | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet (Chewable) | CARBAMAZEPINE 200 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 429 | 2003-02-04 | Supplement to a New Drug Submission (SNDS) | PRODUCT NAME CHANGE FROM CARBAMAZEPINE CR |
| 2753 | 1998-08-21 | New Drug Submission (NDS) |
International API supply for CARBAMAZEPINE
10 valid EDQM Certificates of Suitability from 10 holders. 12 active FDA Drug Master Files.
Request a quote for PHL-CARBAMAZEPINE CR